Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer

被引：0
作者：
Wen Ouyang
Jing Yu
Yan Zhou
Jing Hu
Zhao huang
Junhong Zhang
Conghua Xie
机构：
[1] Zhongnan Hospital of Wuhan University,Department of Radiation and Medical Oncology
[2] Zhongnan Hospital of Wuhan University,Hubei Key Laboratory of Tumor Biological Behaviors
[3] Zhongnan Hospital of Wuhan University,Hubei Clinical Cancer Study Center
来源：
BMC Cancer | / 20卷
关键词：
Non-small cell lung cancer; Epidermal growth factor receptor; Brain metastases; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non-small-cell lung cancer patients: a prospective observational study [J].
Peng, Duanyang ;
Liang, Pingan ;
Zhong, Congying ;
Xu, Peng ;
He, Yanqing ;
Luo, Yuxi ;
Wang, Xia ;
Liu, Anwen ;
Zeng, Zhimin .
BMC CANCER, 2022, 22 (01)
[42]   LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab [J].
Wu, Yahua ;
Du, Bin ;
Lv, Chengliu ;
Ji, Xiaohui ;
Lai, Jinhuo .
ANNALS OF MEDICINE, 2023, 55 (02)
[43]   Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China [J].
Guan, Haijing ;
Liu, Gordon ;
Xie, Feng ;
Sheng, Yanan ;
Shi, Luwen .
CLINICAL THERAPEUTICS, 2019, 41 (11) :2308-2320
[44]   What is the Optimal First-Line Regimen for EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis [J].
Zhang, W. ;
Guo, Z. ;
Ye, L. ;
Chen, Z. ;
Xu, K. ;
Liu, X. ;
Liu, Y. ;
Wang, H. ;
Zhao, L. ;
Zhao, W. ;
He, Y. .
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) :S619-S619
[45]   Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors [J].
Kuiper, Justine L. ;
Smit, Egbert F. .
ONCOLOGY, 2014, 87 (02) :83-94
[46]   Is radical local therapy effective in postoperative recurrent EGFR-mutated non-small cell lung cancer? [J].
Takenaka, Tomoyoshi ;
Yano, Tokujiro ;
Yamazaki, Koji ;
Okamoto, Tatsuro ;
Hamatake, Motoharu ;
Takamori, Shinkichi ;
Kohno, Mikihiro ;
Miura, Naoko ;
Shimokawa, Mototsugu ;
Yoshizumi, Tomoharu ;
Kyushu Univ Lung Surg Study Grp .
THORACIC CANCER, 2023, 14 (18) :1660-1667
[47]   First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases [J].
Tatineni, Vineeth ;
O'Shea, Patrick J. ;
Ozair, Ahmad ;
Khosla, Atulya A. ;
Saxena, Shreya ;
Rauf, Yasmeen ;
Jia, Xuefei ;
Murphy, Erin S. ;
Chao, Samuel T. ;
Suh, John H. ;
Peereboom, David M. ;
Ahluwalia, Manmeet S. .
CANCERS, 2023, 15 (08)
[48]   First-line treatment of EGFR-mutated non-small cell lung cancer with brain metastases: a systematic review and meta-analysis [J].
Ma, Jietao ;
Pang, Xiaoxue ;
Zhang, Shuling ;
Huang, Letian ;
Sun, Li ;
Han, Chengbo .
SCIENTIFIC REPORTS, 2024, 14 (01)
[49]   Downregulation of EGFR in a metastatic brain lesion of EGFR-mutated non-small cell lung cancer using a tyrosine kinase inhibitor: A case report [J].
Takagaki, Masatoshi ;
Kinoshita, Manabu ;
Nishino, Kazumi ;
Nakano, Masakazu ;
Adachi, Hiroko ;
Ueno, Morio ;
Kitamura, Masanori ;
Fujimoto, Yasunori ;
Tashiro, Kei ;
Tomita, Yasuhiko ;
Imamura, Fumio ;
Yoshimine, Toshiki .
ONCOLOGY LETTERS, 2017, 13 (04) :2085-2088
[50]   Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series [J].
Li, Huiying ;
Yu, Tingting ;
Huang, Mingmin ;
Guo, Aibin ;
Qian, Xiaoping ;
Yin, Zhenyu .
ONCOTARGETS AND THERAPY, 2019, 12 :7785-7790
12345